From USFDA
Lupin has received final approval for its Fluocinonide Topical Ointment USP, 0.05% from the United States Food and Drug Administration to market a generic version of County Line Pharmaceuticals, LLC's Lidex Ointment, 0.05%. It is indicated for the relief of the inflammatory and pruritic manifestation of corticosteroid-responsive dermatoses.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
